172 related articles for article (PubMed ID: 9020195)
1. Interaction of methadone with substrates of human hepatic cytochrome P450 3A4.
Iribarne C; Dréano Y; Bardou LG; Ménez JF; Berthou F
Toxicology; 1997 Feb; 117(1):13-23. PubMed ID: 9020195
[TBL] [Abstract][Full Text] [Related]
2. Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes.
Iribarne C; Berthou F; Baird S; Dréano Y; Picart D; Bail JP; Beaune P; Ménez JF
Chem Res Toxicol; 1996 Mar; 9(2):365-73. PubMed ID: 8839037
[TBL] [Abstract][Full Text] [Related]
3. The involvement of cytochrome P450 3A4 in the N-demethylation of L-alpha-acetylmethadol (LAAM), norLAAM, and methadone.
Moody DE; Alburges ME; Parker RJ; Collins JM; Strong JM
Drug Metab Dispos; 1997 Dec; 25(12):1347-53. PubMed ID: 9394023
[TBL] [Abstract][Full Text] [Related]
4. Effects of bioflavonoids on hepatic P450 activities.
Obermeier MT; White RE; Yang CS
Xenobiotica; 1995 Jun; 25(6):575-84. PubMed ID: 7483658
[TBL] [Abstract][Full Text] [Related]
5. Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomes.
Iribarne C; Picart D; Dréano Y; Bail JP; Berthou F
Life Sci; 1997; 60(22):1953-64. PubMed ID: 9180349
[TBL] [Abstract][Full Text] [Related]
6. In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine.
Iribarne C; Picart D; Dréano Y; Berthou F
Fundam Clin Pharmacol; 1998; 12(2):194-9. PubMed ID: 9565774
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of methadone and levo-alpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): potential contribution of intestinal metabolism to presystemic clearance and bioactivation.
Oda Y; Kharasch ED
J Pharmacol Exp Ther; 2001 Sep; 298(3):1021-32. PubMed ID: 11504799
[TBL] [Abstract][Full Text] [Related]
8. Interindividual variation in relative CYP1A2/3A4 phenotype influences susceptibility of clozapine oxidation to cytochrome P450-specific inhibition in human hepatic microsomes.
Zhang WV; D'Esposito F; Edwards RJ; Ramzan I; Murray M
Drug Metab Dispos; 2008 Dec; 36(12):2547-55. PubMed ID: 18809730
[TBL] [Abstract][Full Text] [Related]
9. The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes.
Kerry NL; Somogyi AA; Bochner F; Mikus G
Br J Clin Pharmacol; 1994 Sep; 38(3):243-8. PubMed ID: 7826826
[TBL] [Abstract][Full Text] [Related]
10. Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes.
Berthou F; Dreano Y; Belloc C; Kangas L; Gautier JC; Beaune P
Biochem Pharmacol; 1994 May; 47(10):1883-95. PubMed ID: 8204106
[TBL] [Abstract][Full Text] [Related]
11. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
Heyn H; White RB; Stevens JC
Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadone.
Wu D; Otton SV; Sproule BA; Busto U; Inaba T; Kalow W; Sellers EM
Br J Clin Pharmacol; 1993 Jan; 35(1):30-4. PubMed ID: 8448065
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes.
Shiraga T; Matsuda H; Nagase K; Iwasaki K; Noda K; Yamazaki H; Shimada T; Funae Y
Biochem Pharmacol; 1994 Feb; 47(4):727-35. PubMed ID: 7510480
[TBL] [Abstract][Full Text] [Related]
14. Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man.
Venkatakrishnan K; von Moltke LL; Duan SX; Fleishaker JC; Shader RI; Greenblatt DJ
J Pharm Pharmacol; 1998 Mar; 50(3):265-74. PubMed ID: 9600717
[TBL] [Abstract][Full Text] [Related]
15. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE
Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
[TBL] [Abstract][Full Text] [Related]
16. O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4.
Relling MV; Nemec J; Schuetz EG; Schuetz JD; Gonzalez FJ; Korzekwa KR
Mol Pharmacol; 1994 Feb; 45(2):352-8. PubMed ID: 8114683
[TBL] [Abstract][Full Text] [Related]
17. Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver.
Oetari S; Sudibyo M; Commandeur JN; Samhoedi R; Vermeulen NP
Biochem Pharmacol; 1996 Jan; 51(1):39-45. PubMed ID: 8534266
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of methadone and buprenorphine N-dealkylations by three HIV-1 protease inhibitors.
Iribarne C; Berthou F; Carlhant D; Dreano Y; Picart D; Lohezic F; Riche C
Drug Metab Dispos; 1998 Mar; 26(3):257-60. PubMed ID: 9492389
[TBL] [Abstract][Full Text] [Related]
19. Identification of human liver cytochrome P450 isoforms involved in the in vitro metabolism of cyclobenzaprine.
Wang RW; Liu L; Cheng H
Drug Metab Dispos; 1996 Jul; 24(7):786-91. PubMed ID: 8818577
[TBL] [Abstract][Full Text] [Related]
20. Halofantrine metabolism in microsomes in man: major role of CYP 3A4 and CYP 3A5.
Baune B; Flinois JP; Furlan V; Gimenez F; Taburet AM; Becquemont L; Farinotti R
J Pharm Pharmacol; 1999 Apr; 51(4):419-26. PubMed ID: 10385214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
